What Ozempic does to the gut-brain axis

Weight-loss medication Ozempic may reshape far more than appetite. According to Psychology Today, the drug — which contains semaglutide, a GLP-1 receptor agonist — directly influences the gut-brain axis, the bidirectional communication network linking the digestive system to the nervous system. Ozempic activates GLP-1 receptors along the vagus nerve, signaling fullness to the brain while simultaneously altering the composition of gut bacteria. Those microbial changes have downstream effects: research increasingly links microbiome shifts to mood, anxiety, and mental health. The takeaway: a medication prescribed for weight management may carry underappreciated psychological dimensions, underscoring just how inseparable the brain and gut have become.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton